RSS

antibodies

A collaboration between IONTAS, a company focused on the discovery and optimisation of fully human antibodies, and IGEM Therapeutics, an immunologist-oncology company, for the identification of novel IgE antibodies for cancer targets. more

News

German service and technology provider, ProBioGen, and immune-oncology company, Surface Oncology, have signed a second antibody development project for the development and manufacture of another antibody for potential use in clinical trials. more

News

Biotechnology company, ADC Biotechnology, has announced that it is developing a new ‘downstream bioconjugation’ method that will enable conjugation and antibody purification to be performed concurrently. more

News

Two recently published clinical studies have demonstrated a new approach using antibodies to target specific chemicals in the brain may help significantly reduce the incidence and severity of migraines. more

News

Regeneron Pharmaceuticals has announced plans to discontinue further clinical development of its antibody, suptavumab, for respiratory syncytial virus, as it has not met the primary endpoint of preventing infections in infants in the Phase III study more

News

BBI Solutions have launched more than 20 new antibodies in their product portfolio as a result of demands in the market place. This extended portfolio now includes cardiac, cancer, inflammation and fertility markers. more

News

Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new Discovery Antibodies catalogue. more

News

Alastair Smith, Avacta Life Sciences, outlines the company’s work developing engineered alternatives to antibodies more

Opinion

Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list more

News

A website has been launched by Avacta Life Sciences in order to showcase its new affimer technology. more

Technology

Catalent has signed an exclusive licencing agreement to access Excelimmune's antibody combination therapy technology platform, which has the potential to pave the way for more consistent, cost-effective production of antibody combinations. more

News

The search engine is a powerful clone, antibody and protein products search and buying tool, which gives researchers easy access to millions of products more

News

The agreement will give customers faster, easier access to Abcam’s high-quality antibodies. more

The range is for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting. more

Technology

A study has been published outlining the simultaneous measurement of protein charge and diffusion interaction parameter (kD) more

News

Comparing the antibodies of sharks, which are very old from an evolutionary perspective, with those of humans, a team of researchers at the Technische Universitaet Muenchen and the Helmholtz Zentrum Muenchen discovered stabilising mechanisms... more

News